COVID-19: Implications for business
Our latest perspectives on the coronavirus outbreak, the twin threats to lives and livelihoods, and how organizations can prepare for the next normal.
COVID-19: Briefing note, May 13, 2020
Emerging evidence provides some tantalizing glimpses into the epidemiology of the global pandemic.
By Matt Craven, Mihir Mysore, and Matthew Wilson
As the reopening of economies continues across much of Europe and North America, it’s worth taking stock of the epidemiological situation and trends that will define the months ahead. At the time of this writing, the official counts of cases and deaths from COVID-19 have passed four million and 280,000, respectively. Recent studies have made increasingly clear that each of these figures is a significant underestimate. Population antibody surveys suggest that official counts are underestimating the true number of cases by a factor of five or more (although in several cases the methodology has been called into question) (Exhibit 1).
Συνέχεια ανάγνωσης εδώ
